FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223640259> ?p ?o ?g. }

• W4223640259 endingPage "348" @default.
• W4223640259 startingPage "325" @default.
• W4223640259 abstract "Globally, more than 67 million people are living with the effects of ischemic stroke. Importantly, many stroke survivors develop a chronic inflammatory response that may contribute to cognitive impairment, a common and debilitating sequela of stroke that is insufficiently studied and currently untreatable. 2-Hydroxypropyl-β-cyclodextrin (HPβCD) is an FDA-approved cyclic oligosaccharide that can solubilize and entrap lipophilic substances. The goal of the present study was to determine whether the repeated administration of HPβCD curtails the chronic inflammatory response to stroke by reducing lipid accumulation within stroke infarcts in a distal middle cerebral artery occlusion mouse model of stroke. To achieve this goal, we subcutaneously injected young adult and aged male mice with vehicle or HPβCD 3 times per week, with treatment beginning 1 week after stroke. We evaluated mice at 7 weeks following stroke using immunostaining, RNA sequencing, lipidomic, and behavioral analyses. Chronic stroke infarct and peri-infarct regions of HPβCD-treated mice were characterized by an upregulation of genes involved in lipid metabolism and a downregulation of genes involved in innate and adaptive immunity, reactive astrogliosis, and chemotaxis. Correspondingly, HPβCD reduced the accumulation of lipid droplets, T lymphocytes, B lymphocytes, and plasma cells in stroke infarcts. Repeated administration of HPβCD also preserved NeuN immunoreactivity in the striatum and thalamus and c-Fos immunoreactivity in hippocampal regions. Additionally, HPβCD improved recovery through the protection of hippocampal-dependent spatial working memory and reduction of impulsivity. These results indicate that systemic HPβCD treatment following stroke attenuates chronic inflammation and secondary neurodegeneration and prevents poststroke cognitive decline.SIGNIFICANCE STATEMENT Dementia is a common and debilitating sequela of stroke. Currently, there are no available treatments for poststroke dementia. Our study shows that lipid metabolism is disrupted in chronic stroke infarcts, which causes an accumulation of uncleared lipid debris and correlates with a chronic inflammatory response. To our knowledge, these substantial changes in lipid homeostasis have not been previously recognized or investigated in the context of ischemic stroke. We also provide a proof of principle that solubilizing and entrapping lipophilic substances using HPβCD could be an effective strategy for treating chronic inflammation after stroke and other CNS injuries. We propose that using HPβCD for the prevention of poststroke dementia could improve recovery and increase long-term quality of life in stroke sufferers." @default.
• W4223640259 created "2022-04-15" @default.
• W4223640259 creator A5004628839 @default.
• W4223640259 creator A5005586249 @default.
• W4223640259 creator A5018394545 @default.
• W4223640259 creator A5020054057 @default.
• W4223640259 creator A5025708641 @default.
• W4223640259 creator A5033362933 @default.
• W4223640259 creator A5040695049 @default.
• W4223640259 creator A5045581610 @default.
• W4223640259 creator A5056944235 @default.
• W4223640259 creator A5057230309 @default.
• W4223640259 creator A5062184246 @default.
• W4223640259 creator A5069819013 @default.
• W4223640259 creator A5077559930 @default.
• W4223640259 creator A5078093298 @default.
• W4223640259 date "2021-11-24" @default.
• W4223640259 modified "2023-10-15" @default.
• W4223640259 title "Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental Stroke" @default.
• W4223640259 cites W1508675434 @default.
• W4223640259 cites W1675950512 @default.
• W4223640259 cites W1964111698 @default.
• W4223640259 cites W1966408152 @default.
• W4223640259 cites W1976924995 @default.
• W4223640259 cites W1999235115 @default.
• W4223640259 cites W2002812554 @default.
• W4223640259 cites W2003742510 @default.
• W4223640259 cites W2031672510 @default.
• W4223640259 cites W2035018608 @default.
• W4223640259 cites W2040579356 @default.
• W4223640259 cites W2059092558 @default.
• W4223640259 cites W2060802235 @default.
• W4223640259 cites W2064760068 @default.
• W4223640259 cites W2084292448 @default.
• W4223640259 cites W2084566588 @default.
• W4223640259 cites W2085578246 @default.
• W4223640259 cites W2087591054 @default.
• W4223640259 cites W2092628520 @default.
• W4223640259 cites W2094115917 @default.
• W4223640259 cites W2097948046 @default.
• W4223640259 cites W2106246085 @default.
• W4223640259 cites W2112646710 @default.
• W4223640259 cites W2119904380 @default.
• W4223640259 cites W2128594838 @default.
• W4223640259 cites W2131271579 @default.
• W4223640259 cites W2132194942 @default.
• W4223640259 cites W2134526812 @default.
• W4223640259 cites W2137516955 @default.
• W4223640259 cites W2149107062 @default.
• W4223640259 cites W2153592313 @default.
• W4223640259 cites W2157240187 @default.
• W4223640259 cites W2166069871 @default.
• W4223640259 cites W2167279371 @default.
• W4223640259 cites W2169232663 @default.
• W4223640259 cites W2169456326 @default.
• W4223640259 cites W2179438025 @default.
• W4223640259 cites W2295084974 @default.
• W4223640259 cites W2330691955 @default.
• W4223640259 cites W2511335713 @default.
• W4223640259 cites W2580826849 @default.
• W4223640259 cites W2615761841 @default.
• W4223640259 cites W2770432101 @default.
• W4223640259 cites W2782526370 @default.
• W4223640259 cites W2783180147 @default.
• W4223640259 cites W2886385224 @default.
• W4223640259 cites W2891038139 @default.
• W4223640259 cites W2950437560 @default.
• W4223640259 cites W2990204773 @default.
• W4223640259 cites W3003299879 @default.
• W4223640259 cites W3005638468 @default.
• W4223640259 cites W3013269049 @default.
• W4223640259 cites W3086050495 @default.
• W4223640259 cites W3087316527 @default.
• W4223640259 cites W3090282318 @default.
• W4223640259 cites W3094236759 @default.
• W4223640259 cites W4245690588 @default.
• W4223640259 cites W991097386 @default.
• W4223640259 doi "https://doi.org/10.1523/jneurosci.0933-21.2021" @default.
• W4223640259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34819339" @default.
• W4223640259 hasPublicationYear "2021" @default.
• W4223640259 type Work @default.
• W4223640259 citedByCount "9" @default.
• W4223640259 countsByYear W42236402592022 @default.
• W4223640259 countsByYear W42236402592023 @default.
• W4223640259 crossrefType "journal-article" @default.
• W4223640259 hasAuthorship W4223640259A5004628839 @default.
• W4223640259 hasAuthorship W4223640259A5005586249 @default.
• W4223640259 hasAuthorship W4223640259A5018394545 @default.
• W4223640259 hasAuthorship W4223640259A5020054057 @default.
• W4223640259 hasAuthorship W4223640259A5025708641 @default.
• W4223640259 hasAuthorship W4223640259A5033362933 @default.
• W4223640259 hasAuthorship W4223640259A5040695049 @default.
• W4223640259 hasAuthorship W4223640259A5045581610 @default.
• W4223640259 hasAuthorship W4223640259A5056944235 @default.
• W4223640259 hasAuthorship W4223640259A5057230309 @default.
• W4223640259 hasAuthorship W4223640259A5062184246 @default.
• W4223640259 hasAuthorship W4223640259A5069819013 @default.
• W4223640259 hasAuthorship W4223640259A5077559930 @default.

• next